aiGENE logo — A rapid universal blood test measuring cancer and cancer tre...

aiGENE

A rapid universal blood test measuring cancer and cancer treatment effectiveness

Founded 2019 United States Aurora, United States 4 employees Grant Total: $250.00K Health Care

General Information

Company Name aiGENE
Founded Year 2019
Location United States Aurora, United States
Employees 4
Industries Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with aiGENE. To contact aiGENE, visit a-i-gene.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does aiGENE compare?

A PDF of aiGENE and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting aiGENE soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About aiGENE

aiGENE is a startup founded in 2019 with the slogan "A rapid universal blood test measuring cancer and cancer treatment effectiveness." The company operates in the Health Care industry and is headquartered in the United States. Their latest investment of $250.00K came in the form of a grant from the Advanced Industries Accelerator (AIA) Program on 18 May 2023. aiGENE focuses on providing a rapid, inexpensive, universal, on-site, pan-cancer monitoring of therapy effectiveness, aiming to ultimately offer an inexpensive, universal, pan-cancer screening test. The startup's mission is centered around early identification of hyper-progressive disease or any inactive therapy and switching to an effective therapy, with the belief that such proactive measures can be lifesaving. The emphasis on leveraging advanced technologies for precise cancer detection and treatment effectiveness makes aiGENE an attractive prospect for investors looking to support innovative solutions in the healthcare space. With a promising approach to cancer care, aiGENE presents notable potential for addressing critical healthcare challenges and advancing patient-centered outcomes.

Business keywords: cancer detection, cancer treatment, blood test, therapy effectiveness, pan-cancer monitoring, hyper-progressive disease, therapy efficacy, universal screening test, biomedical innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $250.00K 1
Advanced Industries Accelerator (AIA) Program
18 May 2023

aiGENE Alternatives & Competitors

View All Alternatives
aiGENE vs

At JaxBio we develop a blood test for fast, cheap and highly sensitive diagnosis of cancer.

Grant
11 employees
Health Care
aiGENE vs
Entia
Entia United Kingdom

Unlocking the full potential of cancer therapy with at-home blood monitoring

Series A
32 employees
Biotechnology, Health Care
aiGENE vs
Remicalm
Remicalm United States

Enhancing early detection and effective treatment of various cancers with innovative medical imaging...

Debt Financing
1 employees
Health Care, Manufacturing

FAQ About aiGENE

A rapid universal blood test measuring cancer and cancer treatment effectiveness
aiGENE was founded in 2019.
aiGENE is headquartered in Aurora, United States.
aiGENE operates in Health Care. Its work centres on cancer detection, cancer treatment, blood test and therapy effectiveness.
aiGENE has approximately 4 employees.
aiGENE has completed 1 funding round, raising a total of $250.00K. The latest funding stage is Grant.
Top alternatives and competitors to aiGENE include JaxBio, Entia, Remicalm, Anpac Bio Technology, USA, Kozhnosys. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
aiGENE and JaxBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for aiGENE, https://bouncewatch.com/company/aigene, updated 14 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes